Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.

by Stine Marit Moen, Elisabeth Gulowsen Celius, Leiv Sandvik, Magritt Brustad, Lars Nordsletten, Erik Fink Eriksen, Trygve Holmøy
Published 2012-01-01

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

by Cecilia Smith Simonsen, Cecilia Smith Simonsen, Cecilia Smith Simonsen, Heidi Øyen Flemmen, Heidi Øyen Flemmen, Line Broch, Line Broch, Line Broch, Cathrine Brunborg, Pål Berg-Hansen, Stine Marit Moen, Elisabeth Gulowsen Celius, Elisabeth Gulowsen Celius
Published 2021-06-01

Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.

by Brooke Rhead, Ina S Brorson, Tone Berge, Cameron Adams, Hong Quach, Stine Marit Moen, Pål Berg-Hansen, Elisabeth Gulowsen Celius, Dipen P Sangurdekar, Paola G Bronson, Rodney A Lea, Sean Burnard, Vicki E Maltby, Rodney J Scott, Jeannette Lechner-Scott, Hanne F Harbo, Steffan D Bos, Lisa F Barcellos
Published 2018-01-01